A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications.
The best Bull and Bear pitches based on recency and number of recommendations.
Buying opportunity today for this stock which will benefit greatly if LLY sees success in its Ramu pipeline drug candidate.
Yeah, yeah, yeah, lets see if any of their candidates get past large scale phase III trials. Lets see if the patients have kidneys and liver left afterwards.
Read the most recent pitches from players about DYAX.DL.
Find the members with the highest scoring picks in DYAX.DL.
See what the Wall Street professionals think, according to their public statements and filings.